Sex-Specific Associations Between Depression and Cardiovascular-Kidney-Metabolic Syndrome Progression: A National
Qi Gao1, Weirong Ren1, Xingguo Du1
1Department of Nephrology, Wuhan Fourth Hospital; Wuhan Clinical Research Center for Metabolic Chronic Kidney Disease, Wuhan, Hubei, China.
Aims:
Depressive symptoms are common in women and men with cardiovascular-kidney-metabolic (CKM) syndrome components, yet their prognostic relevance to CKM progression remains unclear. We therefore investigated the sex-specific associations between depressive symptoms and the risk of CKM progression in a national cohort of middle-aged and elderly adults.
Methods:
A total of 5,035 participants aged ≥45 years with CKM stages 0-3 were enrolled. Depressive symptoms were measured using the ten-item Center for Epidemiologic Studies Depression (CESD-10) scale, with scores <10 classified as low and ≥10 as high depressive symptoms. CKM progression was defined as an increase of at least one CKM stage during 4-years follow-up.
Results:
The mean age of the study population was 58.7 (8.6) years, and 53.2% were women. Women had higher baseline CESD-10 scores than men (8.0 [4.0, 13.0] vs. 6.0 [3.0, 10.0]). CKM progression occurred in 898 (33.5%) female and 742 (31.5%) male participants. A significant positive linear association between depressive symptoms and CKM progression was observed in women, but not men (per 5-point increase: women, adjusted OR [aOR], 1.12; 95% CI, 1.05-1.20; men, aOR, 1.00; 95% CI, 0.92-1.08; P for interaction=0.028). Accordingly, women with high depressive symptoms had a significantly increased CKM progression risk compared with those with low depressive symptoms (aOR, 1.35; 95% CI, 1.14-1.60).
Conclusions:
Depressive symptoms are associated with CKM progression in a sex-specific manner, with significant effects observed only among women. These findings support adopting psychological interventions to delay CKM progression, particularly in female populations.
More Related Videos
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
